Neophyte Pharmaceuticals Private Limited
About Neophyte Pharmaceuticals Private Limited
Data last updated:
Neophyte Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2016PTC031554. Its GSTIN is 10AAFCN3014R1ZK (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Satyendra Kumar and Chandresh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Prahlad Vishwakarma Vishwa Enterprises Bander Bagicha Frazer Road, Patna, Bihar, India – 800001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.91 Lakh, a decline of 72% compared to the previous year. For the same year it recorded a net loss of ₹1.4 Lakh (net margin -73.3%) and EBITDA of -₹1.29 Lakh (EBITDA margin -67.3%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Neophyte Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Prahlad Vishwakarma Vishwa Enterprises Bander Bagicha Frazer Road, Patna, Bihar, India – 800001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neophyte Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neophyte Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neophyte Pharmaceuticals Private Limited, buy the company report.
Financials of Neophyte Pharmaceuticals Private Limited
FY 2024 filings availableNeophyte Pharmaceuticals Private Limited reported revenue of ₹1.91 Lakh (down 72% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 72% fall in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -67.3% | ||||
| Net Profit Margin | -73.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neophyte Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neophyte Pharmaceuticals Private Limited
Neophyte Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyendra Kumar | Director | 14 Mar 2018 | 8 Years 7 Months | Current |
| Chandresh Kumar | Director | 14 Mar 2018 | 8 Years 7 Months | Current |
| Rohit Kumar | Director | 14 Mar 2018 | 8 Years 7 Months | Current |
| Preeti Singh | Director | 13 May 2016 | 10 Years 6 Months | Current |
Peer comparison
Neophyte Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neophyte Pharmaceuticals Private Limitedthis company | ₹1.91 Lakh (FY 2024) | -₹1.4 Lakh | -73.3% | -72.0% | Patna, Bihar, India | |
| Vindhyachal Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2019) | -94.0% | Umarkhed, Maharashtra, India | |||
| Megsan Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2025) | -35.0% | Cuttack, Odisha, India | |||
| Experon Pharmaceuticals Private Limited | ₹1.88 Lakh (FY 2025) | -51.0% | Gorakhpur, Uttar Pradesh, India | |||
| Hindraj Pharmaceuticals Private Limited | ₹1.88 Lakh (FY 2023) | 795.0% | Delhi, India |
To see the full peer comparison of Neophyte Pharmaceuticals Private Limited, buy the company report.
Auditor
Neophyte Pharmaceuticals Private Limited is audited by SHLAGHA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHLAGHA & ASSOCIATES | FY 2022 | 031729C |
Shareholding
The shareholding of Neophyte Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Neophyte Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neophyte Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neophyte Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neophyte Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCN3014R1ZK | Bihar | Active | 02 Aug 2018 |
To see the full GST registrations and return filing status of Neophyte Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neophyte Pharmaceuticals Private Limited has 7 board changes on record since 2016: 4 appointments and 3 cessations. The latest: Anuja Kumari ceased to be Director on 15 Mar 2018.
Frequently asked questions
Neophyte Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 May 2016 (10+ years old) and is registered under CIN U74999BR2016PTC031554.
Neophyte Pharmaceuticals has 4 current directors:
- Satyendra Kumar - Director
- Chandresh Kumar - Director
- Rohit Kumar - Director
- Preeti Singh - Director
The latest financial statements of Neophyte Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Neophyte Pharmaceuticals is 10AAFCN3014R1ZK, registered in Bihar.
The CIN (Corporate Identification Number) of Neophyte Pharmaceuticals is U74999BR2016PTC031554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neophyte Pharmaceuticals was incorporated on 13 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Neophyte Pharmaceuticals by revenue are Vindhyachal Pharmaceuticals Private Limited, Megsan Pharmaceuticals Private Limited, Experon Pharmaceuticals Private Limited, Hindraj Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anuja Kumari ceased to be Director on 15 Mar 2018. Megha ceased to be Director on 15 Mar 2018. Ravi Anand ceased to be Director on 15 Mar 2018. Neophyte Pharmaceuticals has 7 board changes on record in total.
The registered office of Neophyte Pharmaceuticals is at CO Prahlad Vishwakarma Vishwa Enterprises Bander Bagicha Frazer Road, Patna, Bihar, India – 800001.
Neophyte Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Neophyte Pharmaceuticals is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
